Skip to main content
Ophthalmologist examining a young patient for keratoconus before corneal cross-linking treatment
Back to ArticlesScientific Authority

Corneal Cross-Linking: How It Stops Keratoconus Progression

Corneal cross-linking strengthens the cornea to halt keratoconus progression. Learn how the procedure works, what recovery involves, and when treatment is most effective.

Miss Tina Khanam
3 min read

Keratoconus is a progressive condition in which the cornea gradually thins and bulges into a cone shape, causing increasingly distorted vision that cannot be fully corrected with standard glasses. Corneal cross-linking (CXL) is the only proven treatment that halts this progression by strengthening the structural bonds within the corneal tissue.

The science behind CXL is elegant in its simplicity. Riboflavin (vitamin B2) eye drops are applied to the cornea, which is then exposed to controlled ultraviolet-A (UVA) light for a defined period. This combination triggers a photochemical reaction that creates new covalent bonds between collagen fibres in the corneal stroma, increasing corneal rigidity by up to 300% according to research published in the American Journal of Ophthalmology.

There are two main protocols: epithelium-off (epi-off) and epithelium-on (epi-on) cross-linking. In epi-off CXL, the outer epithelial layer is gently removed to allow faster riboflavin absorption — this is the gold-standard approach with the strongest evidence base. Epi-on CXL leaves the epithelium intact, offering faster recovery but potentially less consistent riboflavin penetration. Miss Khanam will recommend the protocol best suited to your corneal measurements.

The procedure takes approximately 60 to 90 minutes per eye and is performed under topical anaesthetic drops. Most patients describe mild discomfort during the first two to three days — similar to a scratchy, gritty sensation — which resolves as the epithelium regenerates. A bandage contact lens is placed on the eye to protect it during this initial healing phase.

It is critically important to understand that cross-linking is a stabilisation treatment, not a vision correction procedure. It prevents the cornea from getting worse, but does not reverse existing corneal irregularity. In some patients, modest corneal flattening occurs over the following 12 months, which can improve vision slightly, but this is a secondary benefit rather than the primary goal.

Timing matters enormously with keratoconus. The condition most commonly presents in teenagers and young adults, and early cross-linking can prevent years of progressive vision loss that might otherwise necessitate a corneal transplant. If you or your child has been diagnosed with keratoconus or progressive corneal thinning, seeking prompt specialist assessment is essential.

Following cross-linking, patients with significant corneal irregularity typically continue wearing rigid gas permeable (RGP) contact lenses or scleral lenses to optimise their vision. Some patients may later benefit from combined treatments such as Intacs corneal ring segments or topography-guided laser ablation to further improve visual quality.

Corneal cross-linking at K Vision Centre is performed by Miss Tina Khanam, who brings specialist corneal expertise to every case. Treatment is available from £1,500 per eye, with consultations at Harley Street, Spire Gatwick Park, and Spire St Anthony's.

Written by

Miss Tina Khanam

Consultant Ophthalmic Surgeon at K Vision Centre

Learn more about Miss Tina Khanam

Have Questions About This Topic?

Book a consultation with Miss Tina Khanam to discuss your concerns and explore your options.

Book Consultation